Immunohistochemistry analysis showed significant downregulation GPX4 expression in the Cu2O@EG + MW group after 18 days, weakening the tumor's antioxidant system and promoting ferroptosis (Figure 6g). The gene discussed is GPX4; the disease is neoplasm.